We have qualitatively reviewed this strategy and reaffirmed its Process and People ratings. The team, while experienced, is adjusting after the retirement of a longtime manager. However, the defensive, income-focused process that’s worked well remains intact. The following text is from July 23, 2022.
American Century Equity Income I ACIIX
- NAV / 1-Day Return 8.67 / 0.00
- Total Assets 7.9 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.730%
- Distribution Fee Level Average
- Share Class Type Institutional
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 5.0 Mil
- Status Open
- TTM Yield 2.49%
- Turnover 29%
USD | NAV as of Apr 24, 2024 | 1-Day Return as of Apr 24, 2024, 10:14 PM GMT+0
Morningstar’s Analysis ACIIX
Will ACIIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 28.6
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Johnson & Johnson | 5.31 | 436.2 Mil | Healthcare |
Medtronic PLC | 5.06 | 416.2 Mil | Healthcare |
Colgate-Palmolive Co | 2.61 | 214.7 Mil | Consumer Defensive |
Exxon Mobil Corp | 2.39 | 196.6 Mil | Energy |
Becton Dickinson & Co | 2.38 | 195.8 Mil | Healthcare |
Norfolk Southern Corp | 2.33 | 191.9 Mil | Industrials |
Enterprise Products Partners LP | 2.31 | 189.7 Mil | Energy |
Kimberly-Clark Corp | 2.13 | 175.2 Mil | Consumer Defensive |
RTX Corp | 2.11 | 173.2 Mil | Industrials |
Roche Holding AG | 1.97 | 161.9 Mil | Healthcare |